Yates A D, Watkins W M
Carbohydr Res. 1983 Aug 16;120:251-68. doi: 10.1016/0008-6215(83)88020-3.
A 2-acetamido-2-deoxy-beta-D-glucopyranosyltransferase (N-acetylglucosaminyltransferase) that catalyses the transfer of 2-acetamido-2-deoxy-D-glucose from UDP-2-acetamido-2-deoxy-D-glucose to terminal nonreducing beta-D-galactosyl residues in disaccharides, oligosaccharides, glycoproteins, and glycolipids has been detected in human serum. The preferred acceptors are those with beta-D-galactosyl residues linked (1 leads to 4) to the subterminal sugar residue. Activity is greatest when the second sugar residue is 2-acetamido-2-deoxy-D-glucose but beta-D-Galp-(1 leads to 4)-D-Glc and beta-D-Galp-(1 leads to 4)-D-Man are also good acceptors. Compounds with beta-D-galactosyl groups linked (1 leads to 3) to 2-acetamido-2-deoxy-D-glucose are relatively poor acceptors and beta-D-Galp-(1 leads to 6)-D-GlcNAc is inactive. Oligosaccharides substituted with an L-fucose unit on the beta-D-galactosyl unit or on the adjacent sugar residue failed to accept 2-acetamido-2-deoxy-D-glucose. Similarly, glycoproteins with L-fucose or sialic acid substituents are less effective acceptors before removal of these sugars to expose more beta-D-galactosyl end-groups. The transferred 2-acetamido-2-deoxy-beta-D-glucopyranosyl residue is cleaved from the enzymic reaction products by the N-acetyl-beta-D-glucosaminidase from Jack beans. Methylation analysis of the products of 2-acetamido-2-deoxy-D-glucosyl transfer to N-acetyllactosamine [beta-D-Galp-(1 leads to 4)-D-GlcNAc] and lactose [beta-D-Galp-(1 leads to 4)-D-Glc] revealed that the terminal, nonreducing D-galactosyl group in both these acceptors had been 3-O-substituted with 2-acetamido-2-deoxy-D-glucose. Hence, the enzyme in human serum catalyses, in the presence of Mn2+, the reaction UDP-GlcNAc + beta-D-Galp-(1 leads to 4)-R leads to beta-D-GlcpNAc(1 leads to 3)-beta-D-Galp-(1 leads to 4)-R + UDP and is a UDP-2-acetamido-2-deoxy-D-glucose: beta-D-galactopyranosyl-(1 leads to to 3)-2-acetamido-2-deoxy-beta-D-glucopyranosyltransferase.
在人血清中已检测到一种2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖基转移酶(N-乙酰葡糖胺基转移酶),它催化将2-乙酰氨基-2-脱氧-D-葡萄糖从UDP-2-乙酰氨基-2-脱氧-D-葡萄糖转移至二糖、寡糖、糖蛋白和糖脂中末端非还原性β-D-半乳糖基残基上。优选的受体是那些β-D-半乳糖基残基通过(1→4)连接至次末端糖残基的化合物。当第二个糖残基为2-乙酰氨基-2-脱氧-D-葡萄糖时活性最大,但β-D-Galp-(1→4)-D-Glc和β-D-Galp-(1→4)-D-Man也是良好的受体。β-D-半乳糖基通过(1→3)连接至2-乙酰氨基-2-脱氧-D-葡萄糖的化合物是相对较差的受体,而β-D-Galp-(1→6)-D-GlcNAc无活性。在β-D-半乳糖基单元或相邻糖残基上被L-岩藻糖单元取代的寡糖不能接受2-乙酰氨基-2-脱氧-D-葡萄糖。同样,在去除这些糖以暴露出更多β-D-半乳糖基端基之前,带有L-岩藻糖或唾液酸取代基的糖蛋白是效果较差的受体。从酶促反应产物中,通过来自刀豆的N-乙酰-β-D-葡糖胺酶可裂解转移的2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖基残基。对2-乙酰氨基-2-脱氧-D-葡糖基转移至N-乙酰乳糖胺[β-D-Galp-(1→4)-D-GlcNAc]和乳糖[β-D-Galp-(1→4)-D-Glc]产物的甲基化分析表明,这两种受体中末端的非还原性D-半乳糖基已被2-乙酰氨基-2-脱氧-D-葡萄糖进行了3-O-取代。因此,人血清中的该酶在Mn2+存在下催化反应UDP-GlcNAc + β-D-Galp-(1→4)-R→β-D-GlcpNAc(1→3)-β-D-Galp-(1→4)-R + UDP,是一种UDP-2-乙酰氨基-2-脱氧-D-葡萄糖:β-D-吡喃半乳糖基-(1→3)-2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖基转移酶。